YD Bio (YDESW) Other Non-Current Liabilities (2024 - 2026)

YD Bio (YDESW) has reported Other Non-Current Liabilities for 3 consecutive years, with $4.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $4.5 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $15.0 million, up 397235.86% from the prior year.
• Other Non-Current Liabilities was $4.5 million for Q2 2026 at YD Bio, down from $15.0 million in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $15.0 million in Q4 2025 and troughed at $3773.0 in Q4 2024.
• A 3-year average of $6.5 million and a median of $4.5 million in 2026 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 397235.86% in 2025, down 397235.86% in 2025.
• Over 3 years, Other Non-Current Liabilities stood at $3773.0 in 2024, then soared by 397235.86% to $15.0 million in 2025, then slumped by 69.87% to $4.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $4.5 million (Q2 2026), $15.0 million (Q4 2025), and $3773.0 (Q4 2024), per Business Quant data.